| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticancer drug therapy for patients with renal dysfunction
|
Suyama, Koichi
|
|
|
28 |
5 |
p. 637-643
|
artikel
|
| 2 |
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center
|
Ando, Masashi
|
|
|
28 |
5 |
p. 644-653
|
artikel
|
| 3 |
Clinical value of minimum apparent diffusion coefficient for prediction of clinically significant prostate cancer in the transition zone
|
Ono, Ashita
|
|
|
28 |
5 |
p. 716-723
|
artikel
|
| 4 |
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy
|
Imai, Yu
|
|
|
28 |
5 |
p. 698-706
|
artikel
|
| 5 |
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study
|
Sugawara, Shunichi
|
|
|
28 |
5 |
p. 724-725
|
artikel
|
| 6 |
Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study
|
Kato, Renpei
|
|
|
28 |
5 |
p. 726-727
|
artikel
|
| 7 |
Impact of MIR31HG polymorphisms on risk of breast cancer in Chinese women
|
Wei, Ying
|
|
|
28 |
5 |
p. 664-679
|
artikel
|
| 8 |
Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer
|
Nakajima, Hiroki
|
|
|
28 |
5 |
p. 688-697
|
artikel
|
| 9 |
Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii
|
Maehara, Yoshihiko
|
|
|
28 |
5 |
p. 613-624
|
artikel
|
| 10 |
Nephrotoxicity associated with anticancer agents: perspective on onconephrology from nephrologists
|
Matsubara, Takeshi
|
|
|
28 |
5 |
p. 625-636
|
artikel
|
| 11 |
Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST
|
Teranishi, Ryugo
|
|
|
28 |
5 |
p. 680-687
|
artikel
|
| 12 |
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant
|
Nakai, Chikako
|
|
|
28 |
5 |
p. 654-663
|
artikel
|
| 13 |
Strategy for PSA progression in patients undergoing salvage radiation for biochemical recurrence after radical prostatectomy
|
Saito, Takafumi
|
|
|
28 |
5 |
p. 707-715
|
artikel
|
Tijdschrift beschrijving